Placebo News and Research

RSS

FDA approves new therapy for adult patients with relapsing and primary progressive MS

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

29 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Can insulin, the hormone used for nearly a century to treat diabetes, improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer's disease? Rush University Medical Center is testing this innovative potential treatment as part of a new nationwide study.

25 Mar 2017

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain.

25 Mar 2017

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

For the first time since the corresponding law became effective in 2012, the German Institute for Quality and Efficiency in Health Care has published an assessment of the potential of a new treatment method according to §137e of Social Code Book V.

23 Mar 2017

Study evaluates screening and treatment for subclinical thyroid disease during pregnancy

Observational studies over the past 30 years suggest that subclinical thyroid disease during pregnancy may be associated with adverse outcomes, including a lower-than-normal IQ in offspring.

22 Mar 2017

Study shows efficacy of biologics for mucosal healing in Crohn's disease and ulcerative colitis

Although anti-inflammatory treatments are quite effective at reducing symptoms in patients with Crohn's disease and ulcerative colitis, the mucosal lining of the intestine often remains ulcerated, and many patients still ultimately require surgery.

22 Mar 2017

Study to assess effectiveness of two OTC medications for treating alcoholism in bipolar patients

Researchers have long wondered if medications could treat alcohol abuse. Ihsan Salloum, M.D., chief of the Division of Alcohol and Drug Abuse at the University of Miami Miller School of Medicine, hopes to answer that question in part with a new clinical trial with E. Sherwood Brown, M.D., Ph.D., at UT Southwestern Medical Center in Dallas.

22 Mar 2017

FDA approves drug as add-on treatment for Parkinson's disease patients

The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson's disease who are currently taking levodopa/carbidopa and experiencing "off" episodes.

21 Mar 2017

New gene-silencing drugs cut cholesterol levels by half in early research

The first in a new class of gene-silencing drugs, known as inclisiran, has been shown to halve cholesterol levels in patients at risk of cardiovascular disease.

21 Mar 2017

Supplemental use of vitamin E and selenium did not forestall dementia, study finds

Antioxidant supplements vitamin E and selenium - taken alone or in combination - did not prevent dementia in asymptomatic older men, according to a study published online by JAMA Neurology.

20 Mar 2017

Early treatment with stem cells can safely help recovery in stroke patients, study shows

A multicenter trial looking at whether a single dose of millions of adult, bone-marrow-derived stem cells can aid stroke recovery indicates it's safe and well-tolerated by patients but may not significantly improve their recovery within the first three months, researchers report.

20 Mar 2017

Study links ADHD drug use to improved reading skills among children with dyslexia

A new study of atomoxetine, a drug used to treat attention deficit/hyperactivity disorder (ADHD), was associated with improved reading skills among children 10-16 years of age with either dyslexia alone or with ADHD and dyslexia, compared to placebo.

20 Mar 2017

Research: Surgical approaches may not offer added benefit to patients with tennis elbow

Surgical approaches to treating tennis elbow may not offer additional benefit to patients, as discussed in research presented at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego.

20 Mar 2017

Pacing program can lead to seven-fold reduction in fainting episodes

Patients with recurrent fainting episodes (syncope) who received a pacemaker delivering a pacing program designed to detect and stop the abnormal heart rhythms that precede syncope had a seven-fold reduction in fainting compared with patients in a placebo pacing group, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

Novel synthetic HDL-C injection shows no benefit on arterial plaques

Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, in the arteries, compared with placebo injections, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.

20 Mar 2017

New study provides reassuring information about safety of osteoporosis drug

A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.

17 Mar 2017

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.

17 Mar 2017

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.

15 Mar 2017

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found.

14 Mar 2017

Placebo News and Research

FDA approves new therapy for adult patients with relapsing and primary progressive MS

FDA approves new maintenance therapy for recurrent cancers

SNIFF study to examine safety, efficacy of nasal insulin for treating Alzheimer’s disease

Antidepressants and anti-seizure drugs can effectively treat diabetic nerve pain, research finds

IQWiG assesses potential of MRI-guided high-intensity focused ultrasound therapy for uterine fibroids

Study evaluates screening and treatment for subclinical thyroid disease during pregnancy

Study shows efficacy of biologics for mucosal healing in Crohn's disease and ulcerative colitis

Study to assess effectiveness of two OTC medications for treating alcoholism in bipolar patients

FDA approves drug as add-on treatment for Parkinson's disease patients

New gene-silencing drugs cut cholesterol levels by half in early research

Supplemental use of vitamin E and selenium did not forestall dementia, study finds

Early treatment with stem cells can safely help recovery in stroke patients, study shows

Study links ADHD drug use to improved reading skills among children with dyslexia

Research: Surgical approaches may not offer added benefit to patients with tennis elbow

Pacing program can lead to seven-fold reduction in fainting episodes

Novel synthetic HDL-C injection shows no benefit on arterial plaques

New study provides reassuring information about safety of osteoporosis drug

New class of cholesterol-lowering drug alongside statins can reduce risk of cardiovascular diseases

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News